MGMT and glioblastoma: Unlike traditional focus areas such as IDH mutations or MGMT promoter methylation, which are currently utilized in clinical practice [93, 94], CDCA genes present an underexplored but critical aspect of GBM’s aggressive phenotype, particularly in their role in regulating cell division and proliferation [29].